Thread on Drug Development process 🧡

Hit like & Retweet for more learnings ! πŸ’ŠπŸ§ͺπŸ©ΊπŸ’‰
@unseenvalue

Topics Covered :
1.Introduction to CRO,CDMO,CMO & CRAMS
2.Discovery
3.Clinical Trials
4.Commercialization and Surveillance
5.Success Rates
6.CRO
7.CMO
8.CDMO
9.CRAMS
1. Introduction :
What are CROs, CDMOs, CMOs and CRAMS? How are they different from each other and what value do they add to the Pharma Value Chain? To understand these concepts, we took a look at the drug discovery process.
The APIs manufactured by our Indian players lie at the end of this value chain. There is a whole process that comes before it that takes a lot more time and costs a lot of money.
On average, it takes about 10 to 15 years for a drug to make it to market. It costs hundreds of millions, if not billions of dollars to bring one drug to market.
A drug goes through 3 big phases on it’s way to make it to market - the discovery phase, clinical testing phase and the commercialization phase. Once we understand these phases, it makes it easy to understand the role of CROs and CDMOs
2.Discovery:
The discovery of a new drug starts in the research lab where researchers study hundreds of diseases. They analyse what part of the body a disease affects and what reaction the body has to these diseases.
Once all the causes for the disease have been identified, they investigate what could stop the spread of the disease, what could reduce its effects and what could reverse its effects.
They examine thousands of compounds like natural compounds, synthetic compounds and even bio-engineered compounds that could help with curing or preventing a disease.
The process of narrowing down these compounds is very long. They test these compounds on cell cultures and animals and collect vast amounts of data on how these compounds react. They then narrow these options down to one compound which has the best chance of success to
make the drug out of. This process can take upto 6 years.

Once all this data has been collected, they file an Investigational New Drug (IND) Application with the US FDA. The US FDA reviews the IND within 6 months of filing. Once the IND is approved,
they have permission to test this drug on human volunteers.
3. Clinical Trials:
The drug now moves to the Clinical Trials phase. It will be the first time a novel drug will be given to human beings. The clinical trials itself take place in 3 phases.
In Phase 1, the focus is on safety. In Phase 2, they focus on the effectiveness of the drug and dosing. Phase 3 testing is the largest and is done to make sure that the drug is safe and effective for a wide variety of people. The clinical trial phase can last for 6-7 years.
In Phase 1 -the drug is given to 20-100 HEALTHY(not suffering from the disease) volunteers. This is done to test if the drug is safe for human beings to consume and does not cause any adverse reaction in the body.
In Phase 2, the drug is given to a larger group of patients (several 100) suffering from the disease and is undertaken to test if the drug is actually effective on the disease. The safety tests are also continued from Phase 1 to see if the drug has any adverse side effects.
In Phase 3, the drug is tested on 300-3000 volunteers who are suffering from the disease. The drug is given to people of different genders, age groups, ethnicities to determine if it is effective for a major portion of the population.
Once the Phase 3 trials are completed, the company files an NDA - New Drug Application. The NDA contains the data from all the clinical trials for the FDA to review.
4. Commercialization and Surveillance:
If the FDA approves the NDA, the company can manufacture and market the drugs to the public. But the testing does not end here. The drug now moves into Phase 4 testing.
In Phase 4, the drug which is being sold to the public is continuously monitored to see if it is having the intended effect on the public and not causing any adverse side effects. If it does have any adverse effects, the drug is recalled.
5. Success Rates:
Approximately 70% of the drugs move from Phase 1 to Phase 2, 33% move from Phase 2 to Phase 3, 25-30% move from Phase 3 to Phase 4. About 70-90% of drugs in Phase 4 are successful in staying in the market.
CRO & CDMO :
So where do the CROs and CDMOs come in? Contract research organizations help with the first 2 phases whereas Contract development and manufacturing organizations help with the last 2 phases
6. CROs
CROs support the innovators by providing services from drug discovery right up to commercialization. They provide services like target discovery, pre clinical trials, management of clinical trials, help with regulatory filings and pharmacovigilance(Phase 4).
7. CMOs
Contract manufacturing organizations (CMO) on the other hand provide outsourced manufacturing solutions to the innovator. They are involved with the manufacturing of APIs and Formulations and oftentimes even involved with the final packaging of the product.
8.CDMO
CDMOs are a hybrid between these two. They come in at the clinical trials stage to help with development of the drug, small batch manufacturing for the trials, scaling up the manufacturing process for commercial production, large scale manufacturing and packaging of drugs
9. CRAMS
Finally there are players who provide all the above services right from drug discovery to manufacture and packaging. This is known as CRAMS - Contract Research and Manufacturing.

β€’ β€’ β€’

Missing some Tweet in this thread? You can try to force a refresh
γ€€

Keep Current with Value Educator

Value Educator Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ValueEducator

23 Sep
Unique Business Model
#Tipsindustries

CMP- Rs 1296

A Thread 🧡

Like and Retweet for better reach !
@NeilBahal

Topis covered:
1. Tips Industries Overview
2.Music Segment
3.Monetization
4. Tips Business Model
5.Acquisition Cost
6. Tips Film Business
7. Tips YouTube
8. Why Should Artists Choose Tips Over Other Labels?
9.Financials
10.Future Growth
11.Content Acquisition
12. Conclusion

1. Tips Industries Overview
It was founded by Kumar S. Taurani and Ramesh S. Taurani in 1975.
In 1975, the Taurani brothers used to trade
in LP’s (Long Playing Phonograph Records) for three of the biggest companies in India – HMV, Music India & CBS. By 1977, they had become the biggest dealers for these companies in Western India.
Driven by the ambition of both the brothers started their own record label.
Read 21 tweets
22 Sep
Innovation in the Domestic Poultry Vaccine Business

Hester Biosciences - 2021 Annual Report Summary
#hesterbio

Like and Retweet for better reach
A Thread 🧡

Topics Covered
1. Company overview
2. New launches
3. Key innovation
4. Vaccine plant in Africa
5. Future Opportunities
6. Subsidiaries
7. Manufacturing facilities
8. Revenue Split
9. MD's message
10. Management Discussion and Analysis
11. Financials

1. Company Overview
Hester Biosciences is a leading poultry and animal healthcare company engaged in manufacturing and marketing of vaccines Image
and healthcare products. They currently have a capacity to manufacture 8.99 billion doses. They offer a wide range of high-efficacy vaccines, quality pharmaceutical medicines and affordable feed supplements that protect poultry and animals from diseases. The company has a range
Read 30 tweets
21 Sep
Pioneering oleochemicals in India
Fine Organics Limited πŸ§‘β€πŸ”¬βš—οΈπŸ§ͺ
#fineorganics

Like and retweet for better reach !

Topics covered:
1. Company overview
2. Management
3. Oleochemicals
4. Palm Oil value chain
5. Business Segments
6. Financials
7. Risks
1. Company overview:
Fine Organics commenced operations in 1970 and is the pioneer in oleochemical-based additives in India. The Company has developed a range of 450+ specialty additives, which successfully find their place in foods, plastics, cosmetics, coatings and other key
applications in several industries. The company derives 45% of its revenues domestically and 55% from exports.

2. Management:
i) Prakash Kamat – Executive Director and Chairman : He holds a M. Sc. Tech- Master of Science & Tech (Oils) from Institute of Chemical Technology.
Read 14 tweets
20 Sep
Cost leader in Animal Pharma
NGL Fine Chem πŸ•πŸ•β€πŸ¦ΊπŸΆ
#nglfinechem
Like and Retweet for better reach !
@unseenvalue @punitbansal14

A Thread 🧡

CMP - 2820

Topics Covered :
1. Company overview
2. Management
3. Business segments
4. Business strategy
5. Backward Integration
6. Revenue split
7. Products
8. Manufacturing facilities
9.R&D expenditure
10.Capex
11.Financials
12.Risks

1. Company overview
Established in 1981, NGL Fine Chem manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical products Image
They cater to various Indian and global companies with high quality and reliable products. They acquired Macrotech Polychem for β‚Ή7Cr in 2019 as part of a backward integration strategy.
Read 21 tweets
18 Sep
#Saregama 2021 Annual Report Key Takeways :

A Thread 🧡
Like and retweet for the better reach !

Topics Covered :
1. Music Segment
2. IP Creation
3. IP Monetisation
4. Social Media Platforms
5. Retailing Through Carvaan
6. Carvaan - Product to platform
7. Video Segment
8. Publication Segment
9.Changing media consumption
1. Music Segment
Saregama has India's largest music IP collection with more than 1,30,000 songs.
It has 15% of songs till 1960 contributing 5% of revenue, 27% of songs from 1961-1980 contributing 37% in revenues, 29% of songs from 1981-2000 contributing 28% of revenues Image
Read 25 tweets
18 Sep
100 years of Sulphur Chemistry
Dharamsi Morarji Chemical Company πŸ§ͺπŸ§‘β€πŸ”¬βš—οΈ
#DMCC
#sulphur
A Thread 🧡
CMP - 329

Like and Retweet for better reach !

Topics Covered :
1. Company Overview
2. History
3. Business segments
4. Key products
5. Revenue split
6. Manufacturing Facilities
7. R&D expenditure
8. Capex
9. Financials
10.Future Outlook
11. Risks

1. Company overview: The Dharamsi Morarji Chemical Company Limited (DMCC) is a fully integrated speciality chemicals player in sulphur, boron and ethanol chemistry.
They have over 100 years of experience in sulphur chemistry and have also diversified their operations across other downstream products. Their products find usage in a wide range of industries such as pharmaceuticals, detergents, dyes, fertilisers, pigments and cosmetics.
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(